Table 1 Clinical characteristics of patients with and without DM
From: Impact of diabetes in patients waiting for invasive cardiac procedures during COVID-19 pandemic
| DM | |||
|---|---|---|---|
| Yes (n = 700) | No (n = 1458) | P value | |
| Age | 72.3 ± 10.0 | 69.2 ± 12.7 | < 0.001 |
| Age ≥ 80 (%) | 24.9 | 21.4 | 0.078 |
| Female gender (%) | 34.9 | 39.9 | 0.066 |
| Hypertension (%) | 82.9 | 59.8 | < 0.001 |
| Hypercholesterolemia (%) | 71.0 | 47.9 | < 0.001 |
| Smoking (%) | 30.8 | 29.3 | 0.483 |
| Chronic renal failure (%) | 13.2 | 7.5 | < 0.001 |
| Peripheral artery disease (%) | 14.2 | 9.0 | < 0.001 |
| Previous CAD (%) | 41.7 | 27.4 | < 0.001 |
| Previous infarction (%) | 17.9 | 11.4 | < 0.001 |
| Previous PCI (%) | 23.6 | 15.5 | < 0.001 |
| Previous CABG (%) | 6.7 | 3.4 | 0.001 |
| Previous valve replacement (%) | 3.5 | 4.9 | 0.144 |
| Left ventricular dysfunction (%) | 27.1 | 21.4 | 0.033 |
| NYHA > II (%) | 20.1 | 19.0 | 0.282 |
| CCS > II (%) | 10.0 | 8.4 | 0.001 |
| Main cardiovascular condition (%) | |||
| Ischemic heart disease | 57.6 | 47.0 | < 0.001 |
| Valvular heart disease | 29.2 | 36.9 | |
| Other | 13.3 | 16.2 | |